Dr. Lupașcu has consistently contributed to the field of pharmaceutical sciences through original, high-impact research. Her publications include 37 full articles, 24 in ISI journals, and multiple authored books 📘. She has led a key project on pioglitazone-curcumin-loaded chitosan nanoparticles, a novel drug delivery system targeting Type 2 diabetes mellitus – an area of urgent global healthcare need 🌍. Her H-index (up to 11) and over 500 citations across platforms demonstrate significant scholarly influence 📊.
🎓 Education & Experience
🎓 Education:
-
🧪 Bachelor of Pharmacy, UMF “Grigore T. Popa” Iași (2004–2009)
-
🧬 PhD in Pharmaceutical Chemistry, UMF “Grigore T. Popa” Iași (2009–2013)
-
💊 Residency in Pharmaceutical Laboratory (2015–2019)
-
💼 Residency in General Pharmacy (2020–2023)
🧑🏫 Experience:
-
👩🏫 Assistant, UMF Iași – Faculty of Pharmacy (2013–2016)
-
👩🔬 Lecturer, Pharmaceutical Chemistry (2016–present)
-
📚 Scientific Coordinator – 40 graduation theses
-
👥 Guidance Committee – 3 PhD students
-
🌐 Specializations abroad:
Professional Development 🚀📖
Dr. Lupașcu is actively involved in enhancing her scientific and academic profile through international research networks 🌐, professional societies, and specialized workshops 🧑🔬. She is a steering committee member in the COST Action CA19140 – Focused Ion Technology for Nanomaterials ⚛️ and contributes to the advancement of pharmaceutical chemistry via roles in scientific societies and editorial boards 📖. Her participation in national and international conferences, editorial projects (e.g., Polymers, Pharmaceutics journals) ✍️, and training programs such as drug administration techniques in animal models 🐁 highlights her dynamic engagement with cutting-edge pharmaceutical research and innovation 💡.
Research Focus 🔍🤖
Dr. Lupașcu’s research centers around innovative drug delivery systems, particularly those targeting type 2 diabetes mellitus therapy using biopolymer-based nanoparticles like chitosan 💊🌿. She has explored the synergy between active pharmaceutical ingredients such as pioglitazone and curcumin, embedded within polymer matrices to enhance therapeutic effects 📈. Her interest lies in optimizing the pharmacological profile of oral antidiabetic agents via nanotechnological approaches 🧫. Active in interdisciplinary and translational research, she merges pharmaceutical chemistry, materials science, and nanomedicine 🧪🔍. Her work contributes to developing smarter, safer, and more effective drug systems for chronic diseases 🌡️.
Awards and Honors 🏆🎖️
-
🏆 Best Paper Award – International Conference on Chemistry in Nanosciences and Biomaterials Engineering (June 2022)
-
🥇 Best Oral Presentation – International Conference on Chemistry in Nanosciences and Biomaterials Engineering (June 2021)
-
🎖️ Originality of Results Award – Romanian National Pharmacy Congress, 16th Edition (October 2016)
Publications & Citations 📚
-
📄 An overview of biopolymeric electrospun nanofibers based on polysaccharides for wound healing management 📅 2020 📊 Cited by 160
-
📄 Recent biomedical approaches for chitosan based materials as drug delivery nanocarriers 📅 2021 📊 Cited by 94
-
📄 The synthesis and the biological evaluation of new thiazolidin-4-one derivatives containing a xanthine moiety 📅 2013 📊 Cited by 40
-
📄 New theophylline derivatives with potential pharmacological activity 📅 2010 📊 Cited by 34
-
📄 Synthesis and biological evaluation of the new 1,3-dimethylxanthine derivatives with thiazolidine-4-one scaffold 📅 2017 📊 Cited by 29
-
📄 Development and characterization of novel films based on sulfonamide-chitosan derivatives for potential wound dressing 📅 2015 📊 Cited by 28
-
📄 New ibuprofen derivatives with thiazolidine-4-one scaffold with improved pharmaco-toxicological profile 📅 2021 📊 Cited by 18
-
📄 The influence of a new rutin derivative on homocysteine, cholesterol and total antioxidative status in experimental diabetes in rat 📅 2013 📊 Cited by 17
-
📄 The influence of a new rutin derivative in an experimental model of induced hyperhomocysteinemia in rats 📅 2017 📊 Cited by 16
-
📄 Synthesis and biological evaluation of some new rutin semisynthetic derivatives as antibacterial agents 📅 2012 📊 Cited by 11
-
📄 New derivatives of aryl-propionic acid. Synthesis and biological evaluation 📅 2013 📊 Cited by 6
-
📄 New hydrazones with pyrazolone structure: synthesis, characterization and biological evaluation 📅 2013 📊 Cited by 6
🔍 Conclusion:
Given her pioneering work in nanomedicine, consistent scientific productivity, and prior accolades, Dr. Florentina Lupașcu exemplifies the qualities of a Best Paper Award recipient. Her research offers both academic value and real-world therapeutic potential, making her a standout candidate for further recognition 🥇.